More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...
British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP-1 receptor agonists ...
Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...
Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...
Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.
For Kristian Cook, every pizza box he opened was another door closed on the path to overcoming obesity. “I had massive ...
In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...
Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results